The estimated Net Worth of Christine M Klaskin is at least $1.13 Milion dollars as of 10 September 2021. Ms. Klaskin owns over 16,563 units of Agenus Inc stock worth over $587,553 and over the last 18 years she sold AGEN stock worth over $46,126. In addition, she makes $497,477 as Chief Accounting Officer i Vice President - Finance at Agenus Inc.
Christine has made over 4 trades of the Agenus Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently she exercised 16,563 units of AGEN stock worth $55,652 on 10 September 2021.
The largest trade she's ever made was exercising 16,563 units of Agenus Inc stock on 10 September 2021 worth over $55,652. On average, Christine trades about 555 units every 56 days since 2007. As of 10 September 2021 she still owns at least 104,176 units of Agenus Inc stock.
You can see the complete history of Ms. Klaskin stock trades at the bottom of the page.
Christine M. Klaskin is the Principal Accounting Officer of Agenus Inc. Ms. Klaskin has been Vice President, Finance since October 2006. Since joining Agenus Inc. in 1996 as finance manager, Ms. Klaskin has held various positions within the finance department and has been involved in all equity and debt offerings of the Company including its IPO. Ms. Klaskin is currently a member of the board of directors of American DG Energy Inc. Prior to joining Agenus, Ms. Klaskin was employed by Arthur Andersen as an audit manager. Ms. Klaskin received her Bachelor of Accountancy from The George Washington University.
As the Chief Accounting Officer i Vice President - Finance of Agenus Inc, the total compensation of Christine Klaskin at Agenus Inc is $497,477. There are 8 executives at Agenus Inc getting paid more, with Garo Armen having the highest compensation of $9,937,040.
Christine Klaskin is 54, she's been the Chief Accounting Officer i Vice President - Finance of Agenus Inc since 2018. There are 10 older and 2 younger executives at Agenus Inc. The oldest executive at Agenus Inc is Wadih Jordan, 85, who is the Independent Director.
Christine's mailing address filed with the SEC is C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON, MA, 02421.
Over the last 23 years, insiders at Agenus Inc have traded over $24,466,328 worth of Agenus Inc stock and bought 13,248,226 units worth $63,837,873 . The most active insiders traders include Associates Gp Llcqvt Fund V..., Noubar Afeyan oraz Corp Incyte. On average, Agenus Inc executives and independent directors trade stock every 99 days with the average trade being worth of $2,230,885. The most recent stock trade was executed by Garo H Armen on 15 February 2024, trading 500,000 units of AGEN stock currently worth $325,000.
agenus is an immunology company discovering and developing novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. we are a dedicated group of scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: to discover and develop therapies that can unleash the innate power of the body’s immune system to treat and potentially cure hard-to-treat cancers and other diseases. our product candidates are designed to work by educating and activating the body’s immune system for a precise and potent attack on cancer. our strategy is to help unlock the potential of one of the most exciting breakthrough areas in cancer treatment in decades, and to develop single agent and combination immune-oncology therapies that can help save lives. our approaches are driven by three platform technologies, including: • our antibody platforms, including our proprietary retrocyte display™ and secant® technologies, and our antibody
Agenus Inc executives and other stock owners filed with the SEC include: